XML 41 R29.htm IDEA: XBRL DOCUMENT v3.24.3
Stock Compensation Plans (Tables)
9 Months Ended
Sep. 30, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Activity of Stock Option Plans

Activity of the stock option plans during the nine month period ended September 30, 2024, is summarized as follows:

 

   Number of
Class A
Shares
   Weighted
Average
Exercise
Price (2)
   Number of
Class C
Shares
   Weighted
Average
Exercise
Price (2)
 
                 
Outstanding at January 1, 2024   833,570   $4.91    1,520,062   $5.57 
Adjustment for the effect of stock dividends   38,724         76,005      
Granted   16,500         -      
Exercised   (88,714)        -      
Cancelled   (17,333)        -      
Outstanding at September 30, 2024   782,747   $5.16    1,596,067   $5.57 
                     
As of September 30, 2024:                    
Options exercisable   751,872   $5.05    1,519,817   $5.46 
                     
As of September 30, 2024:                    
Available options for future grant   39,006         556,238      
                     
Weighted average contractual term of options outstanding at September 30, 2024   4.91 years         5.74 years      
                     
Weighted average contractual term of options exercisable at September 30, 2024   4.73 years         5.63 years      
                     
Aggregated intrinsic value of options outstanding at September 30, 2024 (1)  $3,165,305        $5,793,310      
                     
Aggregated intrinsic value of options exercisable at September 30, 2024 (1)  $3,119,776        $5,676,723      

 

 

 

(1) The Company used a stock price of $9.20 as of September 30, 2024 to derive intrinsic value.
(2) Adjusted for the effect of annual stock dividends.

 

 

SECURITY NATIONAL FINANCIAL CORPORATION AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

September 30, 2024 (Unaudited)

 

5) Stock Compensation Plans (Continued)

 

Activity of the stock option plans during the nine month period ended September 30, 2023, is summarized as follows:

 

   Number of
Class A Shares
   Weighted Average Exercise Price (2)   Number of
Class C Shares
   Weighted Average Exercise Price 
                 
Outstanding at January 1, 2023   976,605   $4.56    1,157,203   $5.31 
Adjustment for the effect of stock dividends   38,266         57,859      
Granted   16,000         -      
Exercised   (233,180)        -      
Cancelled   -         -      
Outstanding at September 30, 2023   797,691   $4.78    1,215,062   $5.31 
                     
As of September 30, 2023:                    
Options exercisable   770,066   $4.73    1,141,312   $5.25 
                     
As of September 30, 2023:                    
Available options for future grant   171,386         834,750      
                     
Weighted average contractual term of options outstanding at September 30, 2023   4.69 years         6.15 years      
                     
Weighted average contractual term of options exercisable at September 30, 2023   4.53 years         6.03 years      
                     
Aggregated intrinsic value of options outstanding at September 30, 2023 (1)  $2,438,675        $3,074,037      
                     
Aggregated intrinsic value of options exercisable at September 30, 2023 (1)  $2,398,360        $2,955,012      

 

 

(1) The Company used a stock price of $7.84 as of September 30, 2023 to derive intrinsic value.
(2) Adjusted for the effect of annual stock dividends.
Schedule of Activity Restricted Stock Units

Activity of the RSUs during the nine month period ended September 30, 2024 is summarized as follows:

 

   Number of
Class A Shares
   Weighted
Average Grant
Date Fair Value
 
Non-vested at January 1, 2024   2,245   $7.72 
Granted   -      
Vested   (1,325)     
Non-vested at September 30, 2024   920   $7.99 
           
Available RSUs for future grant   16,540      

 

Activity of the RSUs during the nine month period ended September 30, 2023 is summarized as follows:

 

   Number of
Class A Shares
   Weighted Average Grant Date Fair Value 
Non-vested at January 1, 2023   1,620   $6.48 
Granted   -      
Vested   (810)     
Non-vested at September 30, 2023   810   $6.48 
           
Available RSUs for future grant   18,380